Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
More than 80% of patients with type 2 diabetes mellitus develop hypertension, and approx. 20% of patients with hypertension develop diabetes. This combination of cardiovascular risk factors will account for a large proportion of cardiovascular morbidity and mortality. Lowering elevated blood pressure in diabetic hypertensive individuals decreases cardiovascular events. In patients with hypertension and diabetes, the pathophysiology of cardiovascular disease is multifactorial, but recent evidence points toward the presence of an important component dependent on a low-grade inflammatory process. Angiotensin II may be to a large degree responsible for triggering vascular inflammation by inducing oxidative stress, resulting in up-regulation of pro-inflammatory transcription factors such as NF-κB (nuclear factor κB). These, in turn, regulate the generation of inflammatory mediators that lead to endothelial dysfunction and vascular injury. Inflammatory markers (e.g. C-reactive protein, chemokines and adhesion molecules) are increased in patients with hypertension and metabolic disorders, and predict the development of cardiovascular disease. Lifestyle modification and pharmacological approaches (such as drugs that target the renin–angiotensin system) may reduce blood pressure and inflammation in patients with hypertension and metabolic disorders, which will reduce cardiovascular risk, development of diabetes and cardiovascular morbidity and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACE-I/ARBs are typically prescribed to decrease blood pressure and sympathetic activity (Savoia and Schiffrin, 2007).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Savoia and Schiffrin, 2007
In the citing paper
“there is considerable evidence that its underlying cause is inflammatory in nature [678-686]”
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Research works printed but not linked: 1
- Schöbeck, 2004, Inflammation, immunity, and HMG-CoA reductase inhibitors statins as anti-inflammatory agents?, Circulation, 109, II18
Cited by
Items 101–200 of 332
Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies
Asraf, K., Torika, N., Apte, R. N., & Fleisher-Berkovich, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00116 · Cited by 48
“Although ACEIs are widely prescribed for the treatment of cardiovascular disorders, diabetes and metabolic syndrome, limited clinical studies investigated the anti-inflammatory effects of these agents in humans (Zanchetti and Elmfeldt, 2006; Savoia and Schiffrin, 2007; Kaur et al., 2015).”
BackgroundDecreased circulating T regulatory lymphocytes in obese patients undergoing bariatric surgery
Agabiti-Rosei, C., Trapletti, V., Piantoni, S., Airó, P., Tincani, A., Ciuceis, C. D., Rossini, C., Mittempergher, F., Titi, A., Portolani, N., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197178 · Cited by 49
Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease
Elmarakby, A. A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00606.2011 · Cited by 53
Babu, P. V. A., Si, H., & Liu, D. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200040 · Cited by 48
“Nuclear factor κB (NFκB) plays a major role in governing the vascular inflammatory process by directly up-regulating these chemokines and adhesion molecules [8].”
BackgroundKivimäki, A. S., Ehlers, P. I., Siltari, A., Turpeinen, A. M., Vapaatalo, H., & Korpela, R. (2012) · Journal of Functional Foods · doi:10.1016/j.jff.2012.02.010 · Cited by 51
ELKAHLOUN, A. G., Hafko, R., & Saavedra, J. M. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0167-5 · Cited by 46
“Excessive peripheral AT1R activity associates with hypertension, heart and kidney failure, peripheral vascular and tissue inflammation, and metabolic abnormalities such as insulin resistance [15–17].”
Impact of COVID 19 on erectile function
Adeyemi, D. H., Odetayo, A. F., Hamed, M. A., & Akhigbe, R. E. (2022) · The Aging Male · doi:10.1080/13685538.2022.2104833 · Cited by 47
Is erectile dysfunction a reliable indicator of general health status in men?
Salonia, A., Capogrosso, P., Clementi, M. C., Castagna, G., Damiano, R., & Montorsi, F. (2013) · Arab Journal of Urology · doi:10.1016/j.aju.2013.07.008 · Cited by 46
“paracrine system [86]; this system could be overactive in men with organic ED [87], thus triggering vascular inflammation by regulating the release of inflammatory mediators and by inducing oxidative stress [88].”
BackgroundZhang, L., Yuan, M., Zhang, L. N., Wu, B., & Sun, X. Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.143 · Cited by 43
Predictors of Progression From Prehypertension to Hypertension in Japanese Men
Tomiyama, H., Matsumoto, C., Yamada, J., Yoshida, M., Odaira, M., Shiina, K., Nagata, M., & Yamashina, A. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.49 · Cited by 43
The role of the brain renin-angiotensin system (RAS) in mild traumatic brain injury (TBI)
Vadhan, J. D., & Speth, R. C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107684 · Cited by 42
The number of risk factors increases the recurrence events in ischemic stroke
Juli, C., Heryaman, H., Arnengsih, Ang, E., Defi, I. R., Gamayani, U., & Atik, N. (2022) · European journal of medical research · doi:10.1186/s40001-022-00768-y · Cited by 42
Yogi, Á., Callera, G. E., O'Connor, S. E., He, Y., Corrêa, J. W. D. N., Tostes, R. C., Mazur, A., & Touyz, R. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834786d6 · Cited by 43
Candesartan ameliorates impaired fear extinction induced by innate immune activation
Quiñones-Cordero, M. M., Maldonado, L., Velázquez, B., & Porter, J. T. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.10.017 · Cited by 43
“The renin–angiotensin pathway promotes inflammation (Phillips and Kagiyama, 2002) through angiotensin II stimulation of the angiotensin II type 1 (AT1) receptor (Nishimura et al., 2000; Savoia and Schiffrin, 2007).”
Cardoso, A. M., Abdalla, F. H., Bagatini, M. D., Martins, C. C., Fiorin, F. D. S., Baldissarelli, J., Costa, P., Mello, F. F., Fiorenza, A. M., Serres, J. D. D. S., et al. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt030 · Cited by 48
Metabolic Derangement by Arsenic: a Review of the Mechanisms
Bibha, K., Akhigbe, T. M., Hamed, M. A., & Akhigbe, R. E. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03828-4 · Cited by 44
“Vascular endothelial dysfunction (VED), a risk factor for atherosclerosis, is connected with the pathogenesis of several long-lasting diseases, including atherosclerosis [32], hypertension [101], cardiac failure [35], and diabetic nephropathy [12].”
Polychronopoulou, E., Braconnier, P., & Burnier, M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00136 · Cited by 44
Rodrigues-Díez, R. R., García‐Redondo, A. B., Orejudo, M., Rodrigues‐Díez, R., Briones, A. M., Bosch‐Panadero, E., Kéri, G., Pató, J., Ortíz, A., Salaíces, M., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5500 · Cited by 39
“Next, we investigate whether CCN2(IV) could contribute to vascular inflammation by the early upregulation of key proinflammatory factors involved in cardiovascular diseases (61).”
BackgroundResultInfluentialAngiotensin Receptor Blockers Are Not Just for Hypertension Anymore
Saavedra, J. M. (2021) · Physiology · doi:10.1152/physiol.00036.2020 · Cited by 37
Vascular Aging and Central Aortic Blood Pressure: From Pathophysiology to Treatment
Battistoni, A., Michielon, A., Marino, G., & Savoia, C. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00395-w · Cited by 40
Self-citationYang, Y., & Gao, L. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0922-0 · Cited by 36
“Diabetic patients have chronic low-level inflammation, evidenced by increased proinflammatory cytokines and vascular expression of COX-2, the inducible isoform of COX (Savoia and Schiffrin 2007; Bagi et al. 2006).”
Lima, V. V., Giachini, F. R. C., Carneiro, F. S., Carneiro, Z. N., Fortes, Z. B., de Carvalho, M. H. C., Webb, R. C., & Tostes, R. C. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2008.06.001 · Cited by 44
Penn, A. M. W., Bibok, M. B., Saly, V. K., Coutts, S. B., Lesperance, M., Balshaw, R. F., Votova, K., Croteau, N. S., Trivedi, A., Jackson, A., et al. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1434681 · Cited by 35
“Previous studies have observed that LSEL is a potential cardiac disease marker, with higher levels being predictive of cardiovascular disease (Savoia and Schiffrin 2007).”
BackgroundOh, S., Son, M., Park, C. H., Jang, J. T., Son, K. H., & Byun, K. (2020) · Marine Drugs · doi:10.3390/md18120648 · Cited by 36
“EC death also increases vascular inflammation via promotion of vasoconstrictor agents and adhesion molecules [4,25].”
BackgroundSchiffrin, E. L. (2015) · Clinical and investigative medicine · doi:10.25011/cim.v38i6.26202 · Cited by 36
“Indeed, low-grade inflammation participates as a mechanism of cardiovascular injury and BP elevation [76].”
BackgroundSelf-citationKee, H. J., Ryu, Y., Seok, Y. M., Choi, S. Y., Sun, S., Kim, G. R., & Jeong, M. H. (2019) · Clinical Hypertension · doi:10.1186/s40885-019-0118-8 · Cited by 36
Piragine, E., & Calderone, V. (2020) · Phytotherapy Research · doi:10.1002/ptr.6923 · Cited by 38
Theodorakis, N., Kreouzi, M., Hitas, C., Anagnostou, D., & Nikolaou, M. (2024) · Diagnostics · doi:10.3390/diagnostics14232677 · Cited by 46
“Interestingly, pressure overload models demonstrated that resistin expression was significantly higher in fibrotic cardiac tissues compared to non-fibrotic regions, further linking resistin to pathological cardiac remodeling [94–96].”
Mangoni, A. A., Tommasi, S., Sotgia, S., Zinellu, A., Paliogiannis, P., Piga, M., Cauli, A., Pintus, G., Carru, C., & Erre, G. L. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210106144247 · Cited by 37
Kushwaha, S., & Jena, G. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0707-x · Cited by 33
Lee, T.-I., Kao, Y.-H., Chen, Y.-C., Huang, J.-H., Hsu, M., & Chen, Y.-J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.051 · Cited by 31
Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade
Volpe, M., Cosentino, F., Tocci, G., Palano, F., & Paneni, F. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0205-z · Cited by 32
“All these changes may contribute to accelerate the atherosclerotic process in diabetic disease [ 25 ].”
BackgroundInfluentialFerreira, I., Hovind, P. H., Schalkwijk, C. G., Parving, H., Stehouwer, C. D. A., & Rossing, P. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4470-5 · Cited by 31
Novel predictive risk factor for erectile dysfunction: Serum high‐sensitivity C‐reactive protein
Liu, G., Zhang, Y., Zhang, W., Wu, X., Jiang, H., Huang, H., & Zhang, X. (2022) · Andrology · doi:10.1111/andr.13206 · Cited by 32
Warfel, J. M., & D’Agnillo, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7516 · Cited by 31
Hernanz, R., Martín, Á., Pérez-Girón, J. V., Palacios, R., Briones, A. M., Miguel, M., Salaíces, M., & Alonso, M. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01825.x · Cited by 32
“…blood levels of proinflammatory cytokines, vascular COX-2 expression and oxidative stress together with reduced NO availability are well-established hallmarks of hypertension (Briones et al., 2002; Alvarez et al., 2005; Paravicini and Touyz, 2006; Savoia and Schiffrin, 2007; Virdis et al., 2009).”
BackgroundCarneiro, F. S., Giachini, F. R. C., Lima, V. V., Carneiro, Z. N., Nunes, K. P., Ergul, A., Leite, R., Tostes, R. C., & Webb, R. C. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-031 · Cited by 30
“In this sense, it has been extensively demonstrated that vasoactive peptides, such as angiotensin II and ET-1, exert deleterious effects in the vasculature that are blood pressure-independent (Schiffrin 2005; Savoia and Schiffrin 2007).”
BackgroundCheng, Y., Young, G., Lin, J., Jang, H.-H., Chen, C., Nong, J.-Y., Chen, P., Kuo, C., Kao, S., Liang, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142283 · Cited by 31
Wright, S., O’Prey, F. M., Hamilton, P., Lockhart, C., McCann, A. J., McHenry, M., McGivern, R. C., Plumb, R. D., Finch, M., Bell, A., et al. (2009) · Lupus · doi:10.1177/0961203309104865 · Cited by 30
Inflammation, immunity and development of essential hypertension
Schiffrin, E. L. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000042 · Cited by 31
Self-citationSuthahar, N., Meijers, W. C., Brouwers, F. P. J., Heerspink, H. J. L., Gansevoort, R. T., van der Harst, P., Bakker, S. J. L., & de Boer, R. A. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.035 · Cited by 33
“Increasing levels of copeptin (surrogate marker of vasopressin) also increased the risk of new-onset DM; although copeptin reflects neurohormonal activation, it could also be associated with systemic inflammatory responses through indirect mechanisms involving hypertension and endothelial dysfunction [27,28].”
BackgroundCardoso, A. M., Abdalla, F. H., Bagatini, M. D., Martins, C. C., Zanini, D., Schmatz, R., Jaques, J. A. D. S., Leal, D. B. R., Morsch, V. M., & Schetinger, M. R. C. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000468 · Cited by 32
“Thus, the complex network of enzymes that regulates the ligand availability for P1 and P2 receptors has a central role in defining the immune responses in different tissues [7,8] and the activity of ecto-NTPDases and ADA are particularly important for the balance between the pro and anti-inflammatory effects of releas…”
BackgroundInfluentialPathophysiology of Hypertension
Yamaguchi, I., & Flynn, J. T. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_61 · Cited by 30
“Hyperglycemia and advanced glycosylation end products may also be important contributing factors [438–441].”
BackgroundMechanisms and pharmacotherapy of hypertension associated with type 2 diabetes
Kamalumpundi, V., Shams, E., Tucker, C., Cheng, L., Peterson, J., Thangavel, S., Ofori, O., & Correia, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115304 · Cited by 38
Li, C.-M., Dong, X., Fan, X.-D., Wu, J.-H., Wang, Q.-H., Tian, X.-L., Guo, D.-J., Wong, M., Tai-qiu, Q., & Chan, S. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31825b512d · Cited by 28
Li, C., Samaranayake, N., Ong, K. L., Wong, H. K., & Cheung, B. M. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039760 · Cited by 28
“[9,11,17,18,19,20] As endothelial dysfunction and inflammation are two key mechanisms in the development and progression of hypertension, [21,22] this provides an explanation of how chronic HCMV infection may result in hypertension.”
BackgroundKaur, J., Reddy, K., & Balakumar, P. (2010) · Cardiovascular Toxicology · doi:10.1007/s12012-010-9086-7 · Cited by 27
“VED is an insidious condition as it is strongly associated with the pathogenesis of various cardiovascular disorders such as atherosclerosis [5], hypertension [6], heart failure [2] and diabetic nephropathy.”
BackgroundYang, X.-L., Kim, C. K., Kim, T. J., Sun, J., Rim, D., Kim, Y. J., Ko, S., Jang, H., & Yoon, B. (2015) · Inflammation Research · doi:10.1007/s00011-015-0895-9 · Cited by 29
ŞAHİN, T. D., Yazır, Y., Utkan, T., Gacar, G., Rençber, S. F., & Göçmez, S. S. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0113 · Cited by 27
“Tumor necrosis factor alpha (TNF- ) is a proinflammatory cytokine and contributes to many cardiovascular system disorders (Savoia and Schiffrin 2007).”
BackgroundInfluentialHong, S., Dimitrov, S., Cheng, T., Redwine, L. S., Pruitt, C., Mills, P. J., Ziegler, M. G., Green, J. M., Shaikh, F., & Wilson, K. L. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.012 · Cited by 27
“…inflammatory and atherogenic processes in order for better risk assessment for future CVD. Migration and infiltration of inflammatory immune cells, such as monocytes into the vascular endothelium, is a key process in the pathogenesis of vascular inflammatory disease (Savoia and Schiffrin, 2007).”
BackgroundHouser, M. C., Mac, V., Smith, D. J., Chicas, R. C., Xiuhtecutli, N., Flocks, J. D., Elon, L., Tansey, M. G., Sands, J. M., McCauley, L., et al. (2021) · Biological Research For Nursing · doi:10.1177/10998004211016070 · Cited by 26
“To evaluate baseline dehydration, we classified USG values according to whether they were 1.020 or 1.020, defining the former as dehydration based upon the hypohydration threshold guidelines of the American College of Sports Medicine (Sawka et al., 2007).”
MethodInfluentialImmune Modulation of Resistance Artery Remodelling
Schiffrin, E. L. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00760.x · Cited by 26
Self-citationO'Hagan, T., Wharton, W., & Kehoe, P. G. (2012) · Europe PMC (PubMed Central) · Cited by 38
Meyer, N., Brodowski, L., von Kaisenberg, C., Schröder‐Heurich, B., & von Versen‐Höynck, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189696 · Cited by 29
“NF-κB expression correlates with upregulation of chemokines in human cardiovascular disease [25,77,78].”
BackgroundSavoia, C., & Schiffrin, E. L. (2013) · Hypertension · doi:10.2217/ebo.12.172 · Cited by 26
Self-citationRyu, S., Shin, J., Cho, Y., Kim, H. K., Paik, S. H., Lee, J. H., Chi, Y. H., Kim, J. H., Kim, J. H., & Lee, K. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00859 · Cited by 30
Sallam, N. A., Khazaei, M., & Laher, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/149678 · Cited by 25
“CRP is related to insulin resistance and is a marker of endothelial dysfunction [32].”
BackgroundChia, E. W., Kagota, S., Wijekoon, E. P., & McGuire, J. J. (2011) · BMC Pharmacology · doi:10.1186/1471-2210-11-10 · Cited by 26
“There is also a broad literature contending that chronic elevated levels of ANG II elicits increased pro-inflammatory signalling by cytokines and pro-thrombotic conditions that contribute to the disruption of normal endothelial and vascular smooth muscle cell biology [29].”
BackgroundBenter, I. F., Sarkhou, F., Al-Khaldi, A. T., Chandrasekhar, B., Attur, S., Dhaunsi, G. S., Yousif, M. H. M., & Akhtar, S. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1057150 · Cited by 23
“[5,7,40]), the present study indicated that EGFR-ErbB2 signaling via activation of NF-kB is an important signaling pathway leading to hyperglycemia-induced VSMC apoptosis – a common cellular feature of diabetic vascular dysfunction.”
BackgroundCCR5 deficiency does not reduce hypertensive end-organ damage in mice
Krebs, C. F., Fraune, C., Schmidt-Haupt, R., Turner, J., Panzer, U., Quang, M. N., Tannapfel, A., Velden, J., Stahl, R. A. K., & Wenzel, U. O. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.243 · Cited by 27
Sourris, K. C., Lyons, J. G., Dougherty, S. L., Chand, V., Straznicky, N. E., Schlaich, M. P., Grima, M. T., Cooper, M. E., Kingwell, B. A., de Courten, M., et al. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0850 · Cited by 28
“The relationship between CLAIS and hypertension is likely due to both direct AGE deposition in the vasculature which contributes to arterial stiffening as well as impaired capacity of the endothelium to generate vasodilating factors [34, 36].”
InfluentialStructural Alterations in Small Resistance Arteries in Obesity
Rizzoni, D., Ciuceis, C. D., Porteri, E., Semeraro, F., & Rosei, E. A. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00786.x · Cited by 22
Guan, Z., Fuller, B. S., Yamamoto, T., Cook, A. K., Pollock, J. S., & Inscho, E. W. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00743.2009 · Cited by 22
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases
García, R. D., Asensio, J. A., Perdicaro, D. J., & Peral, M. D. L. Á. (2022) · Current Vascular Pharmacology · doi:10.2174/1570161120666220201160038 · Cited by 22
Afghahi, H., Svensson, M. K. E., Pirouzifard, M., Eliasson, B., & Svensson, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3548-1 · Cited by 21
“Elevated BP is associated with an increase in the risk of cardiovascular disease (CVD) and death in the general population [2–5]; when hypertension is combined with diabetes, the CVD risk increases further [6].”
BackgroundRelationship between PMN-endothelium interactions, ROS production and Beclin-1 in type 2 diabetes
Marañón, A., Iannantuoni, F., Abad‐Jiménez, Z., Canet, F., Díaz-Pozo, P., López‐Domènech, S., Jover, A., Morillas, C., Mariño, G., Apostolova, N., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101563 · Cited by 21
“characteristic of type 2 diabetes favour PMN-endothelial interactions throughout the vasculature, not only at the site of inflammation [17].”
BackgroundBalla, S. A. (2014) · American Journal of Health Research · doi:10.11648/j.ajhr.20140206.16 · Cited by 21
Musial, D. C., da Silva, E. D., da Silva, R. M., Miranda‐Ferreira, R., Lima‐Landman, M. T. R., Jurkiewicz, A., García, A. G., & Jurkiewicz, N. H. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113496441 · Cited by 21
DEEDWANIA, P. C., & Srikanth, S. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.1.127 · Cited by 24
Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension
Osmond, D. A., Zhang, S., Pollock, J. S., Yamamoto, T., Miguel, C. D., & Inscho, E. W. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00444.2013 · Cited by 22
Ciuceis, C. D., Rossini, C., Tincani, A., Airó, P., Scarsi, M., Agabiti-Rosei, C., Ruggeri, G., Caimi, L., Ricotta, D., Agabiti‐Rosei, E., et al. (2016) · Blood Pressure · doi:10.1080/08037051.2016.1184495 · Cited by 21
Ni, X., Li, X., Fan, Z., Ai, W., Zhang, H., Zhang, L., Li, L., Si, J., & Ma, K. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0106-0 · Cited by 20
Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction
Kaur, T., Goel, R. K., & Balakumar, P. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0416-x · Cited by 19
“VED plays a major role in the pathogenesis of various cardiovascular disorders such as hypertension (Savoia and Schiffrin, 2007), atherosclerosis (Davignon and Ganz, 2004), heart failure (Desjardins and Balligand, 2006) myocardial infarction (Pesic et al., 2006) and stroke (Papaharalambus and…”
BackgroundBalgobin, S., Basak, S., Teoh, C. W., & Noone, D. G. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06163-x · Cited by 21
“AngII can upregulate NADPH oxidase by activating the proto-oncogene cSrc, leading to the expression of the subunits of NAPDH oxidase [38].”
Bułdak, Ł., Łabuzek, K., Bułdak, R. J., Machnik, G., Bołdys, A., Basiak, M., & Okopień, B. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.2977 · Cited by 19
“Low‑grade inflammation, which is accompanied by oxidative stress, is detected in patients suffering from various diseases including diabetes (2), obesity (3), coronary heart disease (4) and hypertension (5).”
RetractedAnalysis of Genetic Host Response Risk Factors in Severe COVID-19 PatientsPreprint
Taylor, K., Das, S., Pearson, M. W., Kozubek, J. A., Pawłowski, M., Jensen, C. E., Skowron, Z., Møller, G. L., Strivens, M. A., & Gardner, S. (2020) · medRxiv · doi:10.1101/2020.06.17.20134015 · Cited by 24
Feng, X., Mei, Y., Wang, X., Cui, L., & Xu, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1192113 · Cited by 19
Magen, E., Feldman, A., Minz, E., Mishal, J., Cohen, Z., Schlezinger, M., Alon, D. B., Chernyavsky, A., Linov, L., & Sthoeger, Z. M. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181c6a968 · Cited by 18
Hajmohammadi, M., Khaksari, M., Soltani, Z., Shahrokhi, N., Najafipour, H., & Abbasi, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01043 · Cited by 19
Multi-Ligand Poly(l-Lactic-co-Glycolic Acid) Nanoparticles Inhibit Activation of Endothelial Cells
Xu, H., Kona, S., Su, L.-C., Tsai, Y.-T., Dong, J.-F., Brilakis, E. S., Tang, L., Banerjee, S., & Nguyen, K. T. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9460-5 · Cited by 17
Dolber, P. C., Jin, H., Nassar, R., Coffman, T. M., Gurley, S. B., & Fraser, M. O. (2013) · Neurourology and Urodynamics · doi:10.1002/nau.22511 · Cited by 17
“Thus, most diabetics develop hypertension and many hypertensives develop diabetes, and treatment with angiotensin converting enzyme inhibitors or type 1 AngII receptor antagonists prevents or delays new onset diabetes.(4,5) This is important because RAS overactivitymodifies smooth muscle function.”
BackgroundTetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension
Bivol, L. M., Berge, R. K., & Iversen, B. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00590.2007 · Cited by 17
“Inflammatory markers are increased in hypertension (40) and may contribute to vascular and tubulointerstitial inflammation followed by fibrosis (39).”
BackgroundOhara, N., Kasama, K., Naito, Y., Nagata, T., Saito, Y., Kuwagata, M., & Okuyama, H. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.04.015 · Cited by 17
Vilhena, J. C., Cunha, L. L. D. M., Jorge, T. M., Lucena-Machado, M. D., Soares, R. D. A., Santos, I. B., de Bem, G. F., Fernandes‐Santos, C., Ognibene, D. T., de Moura, R. S., et al. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001003 · Cited by 17
Wang, Z., Rivas‐Serna, I. M., Monirujjaman, M., Fernando, I. P. S., Mazurak, V. C., & Wu, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105417 · Cited by 17
Ciuceis, C. D., Salvetti, M., Paini, A., Rossini, C., Muiesan, M. L., Duse, S., Caletti, S., Coschignano, M. A., Semeraro, F., Trapletti, V., et al. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1696-7 · Cited by 16
Liu-Galvin, R. E., Orlando, F. A., Saguil, A. A., Jo, A., Smith, K., Miller, A. M., Nelson, D. S., Sanders, E. C., & Mainous, A. G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1695935 · Cited by 16
Awuah, A., Moore, J. S., Nesbit, M. A., Ruddock, M. W., Brennan, P., Mailey, J. A., McNeil, A. J., Jing, M., Finlay, D., Trucco, E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-10491-7 · Cited by 15
Redox mechanisms of the beneficial effects of heme oxygenase in hypertension
Chan, E. C., Dusting, G. J., Liu, G., & Jiang, F. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000179 · Cited by 14
“Vascular inflammation may be a result of chronic hypertension, and may be involved in mediating the proatherogenic effect of hypertension [45].”
BackgroundKathuria, S., Mahadevan, N., & Balakumar, P. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1505-6 · Cited by 15
Poitras, V. J., Bentley, R. F., Hopkins-Rosseel, D. H., LaHaye, S. A., & Tschakovsky, M. E. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00758.2014 · Cited by 14
Sullivan, J. C., Pardieck, J., Doran, D., Zhang, Y., She, J., & Pollock, J. S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01093.2008 · Cited by 14
The Flame That Lights the Fire
Schiffrin, E. L. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.115402 · Cited by 14
Self-citationThe effects of blocking Angiotensin receptors on early stages of diabetic nephropathy.
Gheissari, A., Javanmard, S. H., Shirzadi, R., Amini, M., & Khalili, N. (2012) · PubMed Central · Cited by 13
Durazzo, T. C., Nguyen, L.-C., & Meyerhoff, D. J. (2020) · Alcohol and Alcoholism · doi:10.1093/alcalc/agaa034 · Cited by 14
“Hypertension, type 2 diabetes mellitus, hepatitis C seropositivity and hyperlipidemia are suggested to promote proinflammatory conditions that may directly contribute to altered arterial integrity and function through atherosclerotic-related stenosis and/or altered hemodynamic regulation (Savoia and Schiffrin, 2007; V…”
BackgroundJulius, S., Egan, B. M., Kaciroti, N., Nesbitt, S. D., & Chen, A. K. (2013) · Journal of Hypertension · doi:10.1097/hjh.0000000000000032 · Cited by 14
Hay fever and hypertension in the US adult population
Li, C., Cheung, C., Cheung, T. T., Samaranayake, N., & Cheung, B. M. Y. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.804545 · Cited by 13
“Low-grade chronic inflammation plays an important role in both the development and the progression of hypertension (2).”
BackgroundLebalado, L. P., & Mulyati, T. (2014) · Journal of Nutrition College · doi:10.14710/jnc.v3i3.6602 · Cited by 13
P2 Receptors in Renal Autoregulation
Guan, Z., Fellner, R., Beusecum, J. P. V., & Inscho, E. W. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660152 · Cited by 15
Couto, N. F., Fancher, I. S., Granados, S. T., Silva, J. C., Beverley, K., Ahn, S. J., Hwang, C., Phillips, S. A., & Levitan, I. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00732.2023 · Cited by 12
Metadata
- Authors
- Savoia, C., & Schiffrin, E. L.
- Affiliations
- Jewish General Hospital (CA)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2007-03-01
- Volume
- 112
- Issue
- 7
- Pages
- 375-384
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1975582897
- Cited by
- 326
- References
- 129
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 21 · 2019: 14 · 2018: 15 · 2017: 20 · 2016: 18 · 2015: 24 · 2014: 21 · 2013: 23 · 2012: 21
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- vascular inflammation, hypertension, type 2 diabetes, angiotensin II, oxidative stress, NF-κB, endothelial dysfunction, cardiovascular risk, C-reactive protein, chemokines, adhesion molecules, renin-angiotensin system, blood pressure reduction, lifestyle modification
- MeSH terms
- Aldosterone, Angiotensin II, Diabetes Mellitus, Type 2, Humans, Hypertension, Renin-Angiotensin System, Vasculitis, Cell Adhesion Molecules, Cytokines, NF-kappa B, Disease Progression, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.